Medtronic plc (NYSE: MDT ) has released its third-quarter fiscal 2025 financial results, showcasing a solid performance that exceeded earnings expectations. Financial Highlights: Revenue: The company reported worldwide revenue of $8.292 billion, marking a 2.5% increase as reported and a 4.1% rise on an organic basis. Earnings: Net income for the quarter stood at $1.294 billion, translating to earnings per share (EPS) of $1.01. Adjusted for amortization and non-recurring costs, EPS reached $1.39, surpassing the consensus estimate of $1.36. Key Growth Drivers: A significant contributor to this quarter's performance was the strong demand for Medtronic's advanced heart-surgery devices, particularly those utilizing pulsed-field ablation technology. This segment experienced over 20% revenue growth, reflecting the company's successful investments in innovative cardiac solutions. Market Performance and Outlook: As of February 18, 2025, Medtronic's stock is trading at $92.81. ...
A periodical exploring the art of investing, financial knowledge, and the stories that shape a meaningful life.